Stocktoria

Disc Medicine, Inc. IRON

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-08-12

Disc Medicine, Inc. statistics & valuation

Market cap$2.9B
P / B3.9×
Return on equity-28.7%
Net cash$62.0M
Enterprise value USD$2.8B
Earnings yield EBIT/EV-8.4%
Return on capital-30.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-26.50% -22.10% -24.70% -28.70% 202020212022202320242025
Shares outstanding
15.6M 909418 17.4M 24.4M 29.9M 37.9M 202020212022202320242025
Net debt ($)
$9.5M -$360.4M -$164.1M -$62.0M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-490.90% -38.90% -23.40% -20.80% -22.00% -26.30% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
0.00× 0.06× 0.04× 202020212022202320242025
EPS ($)
-$40.95 -$45.05 -$3.42 -$3.96 -$6.01 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-26.3%-22.0%-20.8%-23.4%-38.9%-490.9%
Return on equity-28.7%-24.7%-22.1%-26.5%56.0%141.8%
Debt / equity0.04×0.06×0.00×——-0.49×
Current ratio21.9421.1717.068.796.740.20

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.